Restoring Lives
One Story At A Time

We are Assertio — an assertive, energetic, and empathetic pharmaceutical company built around the mission of advancing patient care. Formerly known as Depomed, we have transformed our company with a current focus on three FDA-approved products in our core areas of neurology, orphan, and specialty medicines, as we continue to identify, license, and develop new products that offer enhanced options for patients who may be underserved by existing therapies. More

In the News

October 17, 2018

Assertio Therapeutics to Participate in Upcoming Investor ConferencesRead More

October 8, 2018

Assertio Therapeutics to Report Third-Quarter 2018 Financial Results After The Close of Markets on Thursday, November 8, 2018Read More

September 5, 2018

Assertio Therapeutics to Present at the 16th Annual Morgan Stanley Global Healthcare ConferenceRead More

More News